Please feel free to contact us for a quote and further discussion with our scientists.
Datasheets
| Specifications | |
|---|---|
| Product Description | Atorvastatin is a statin-class inhibitor of HMG-CoA reductase that binds to the catalytic domain of HMGCR, competitively blocking substrate access. It serves as a warhead for bifunctional chemical agents targeting HMGCR for proteasomal degradation. |
| Molecular Formula | C33H35FN2O5 |
| Molecular Weight (Da) | 558.6 |
| Chemical Name | (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid |
| Chemical Structure |  |
| Purity | 0.99 |
| Size | 5 mg |
| Physical State | Powder |
| Storage | The power can be stored at 4 °C for 2 years or at -20 °C for 3 years. |
| Target Information | |
|---|---|
| Target Name | HMGCR |
| Alternative Names | LDLCQ3, LGMDR28, MYPLG |
| Introduction | HMGCR (HMG-CoA reductase) is the rate-limiting enzyme of the mevalonate pathway, containing an N-terminal membrane-anchoring domain with eight transmembrane helices and a C-terminal catalytic domain. It catalyzes the conversion of HMG-CoA to mevalonate. |
| Gene ID | 3156 |
| UniProt ID | P04035 |
| Related Disease | Hypercholesterolemia, cardiovascular disease, hepatocellular carcinoma, prostate cancer |
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
